Mono Pharmacare Limited (NSE:MONOPHARMA)
India · Delayed Price · Currency is INR 8.90
+0.40 (4.71%)
Oct 9, 2026, 1:20 PM IST
Mono Pharmacare Revenue
In the fiscal year ending March 31, 2026, Mono Pharmacare had annual revenue of 1.66B INR, down -1.63%. Mono Pharmacare had revenue of 994.04M in the half year ending March 31, 2026, with 77.92% growth. That makes Mono Pharmacare the 34,659th largest company in the world by revenue and 2,689th in India.
Revenue
1.66B
Revenue Growth
-1.63%
P/S Ratio
0.09
Revenue / Employee
25.89M
Employees
64
Market Cap
157.25M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.66B | -27.38M | -1.63% |
| Mar 31, 2025 | 1.68B | 460.68M | 37.65% |
| Mar 31, 2024 | 1.22B | 892.22M | 269.20% |
| Mar 31, 2023 | 331.44M | -39.50M | -10.65% |
| Mar 31, 2022 | 370.93M | 87.15M | 30.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 599.11B |
| Apollo Hospitals Enterprise | 264.30B |
| Divi's Laboratories | 112.30B |
| Lenskart Solutions | 96.34B |
| Mohini Health & Hygiene | 1.44B |
| Vivimed Labs | 763.08M |
| Sunrest Lifescience | 708.33M |
| Nidan Laboratories and Healthcare | 255.42M |